Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-16-087910
Filing Date
2016-01-04
Accepted
2016-01-04 17:20:17
Documents
1
Period of Report
2016-01-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2918
  Complete submission text file 0001209191-16-087910.txt   4311
Mailing Address
Business Address
SANDELL SCOTT D (Reporting) CIK: 0001237289 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37368 | Film No.: 161319200

Mailing Address 101 PARK DRIVE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RY
Business Address 101 PARK DRIVE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RY 44 1235 430000
Adaptimmune Therapeutics PLC (Issuer) CIK: 0001621227 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 0630
SIC: 2836 Biological Products, (No Diagnostic Substances)